Literature DB >> 10806301

Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.

Y Noguchi1, T Okamoto, D Marat, T Yoshikawa, A Saitoh, C Doi, K Fukuzawa, A Tsuburaya, S Satoh, T Ito.   

Abstract

The expression of facilitative glucose transporter isoforms in colon adenocarcinoma and the possible role of k-ras in inducing GLUT (glucose transporter) mRNA were studied. RT-PCR demonstrated GLUT2 and GLUT3 expression in 100% of the ten normal colon mucosa samples but detected no GLUT1 mRNA. By contrast, GLUT1 mRNA was detected in all 20 (100%) colon cancer samples examined. GLUT4 mRNA was not detected in either normal mucosa or colon cancer tissues. Semiquantitative PCR demonstrated equal amounts of GLUT2 and GLUT3 mRNA in both normal mucosa and colon cancer samples. A point mutation in codon 12 of k-ras was detected in only six of the 20 (30%) colon cancer samples. Thus, a major difference between normal colon epithelia and colon cancer was the acquisition of GLUT1 expression, which was unlikely to have been induced by a point mutation in codon 12 of k-ras.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806301     DOI: 10.1016/s0304-3835(00)00354-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Altered glucose metabolism in Harvey-ras transformed MCF10A cells.

Authors:  Wei Zheng; Fariba Tayyari; G A Nagana Gowda; Daniel Raftery; Eric S McLamore; D Marshall Porterfield; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

2.  Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency.

Authors:  June-Hyung Kim; Hee Young Kim; Young-Kyoung Lee; Young-Sil Yoon; Wei Guang Xu; Joon-Kee Yoon; Sung-E Choi; Young-Gyu Ko; Min-Jung Kim; Su-Jae Lee; Hee-Jung Wang; Gyesoon Yoon
Journal:  Autophagy       Date:  2011-10-01       Impact factor: 16.016

3.  Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes.

Authors:  Pascale Anderle; Thierry Sengstag; David M Mutch; Martin Rumbo; Viviane Praz; Robert Mansourian; Mauro Delorenzi; Gary Williamson; Matthew-Alan Roberts
Journal:  BMC Genomics       Date:  2005-05-10       Impact factor: 3.969

4.  Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.

Authors:  Jihye Yun; Carlo Rago; Ian Cheong; Ray Pagliarini; Philipp Angenendt; Harith Rajagopalan; Kerstin Schmidt; James K V Willson; Sandy Markowitz; Shibin Zhou; Luis A Diaz; Victor E Velculescu; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Science       Date:  2009-08-06       Impact factor: 47.728

Review 5.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

6.  Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.

Authors:  Xiaoyu Pei; Feifei Luo; Jun Zhang; Wulian Chen; Chen Jiang; Jie Liu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

7.  SGLT gene expression in primary lung cancers and their metastatic lesions.

Authors:  N Ishikawa; T Oguri; T Isobe; K Fujitaka; N Kohno
Journal:  Jpn J Cancer Res       Date:  2001-08

8.  Glucose transporters as markers of diagnosis and prognosis in cancer diseases.

Authors:  Leszek Szablewski
Journal:  Oncol Rev       Date:  2022-02-22

9.  Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells.

Authors:  C-Y Huang; W-T Kuo; Y-C Huang; T-C Lee; L C H Yu
Journal:  Cell Death Dis       Date:  2013-05-02       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.